Onset of sex difference i n c i r c u l a t i n g l e v e l s of SHBG i n humans with age.
mixed r e s u l t s with 11 of t h e MPHD-patients showing a decreased l e v e l of stimulation. However, when t h e c i r c u l a t i n g l e v e l s of t h e major adrenal androgen dehydroepiandrosterone (DHA) were examined, t h e group of GH-deficient p a t i e n t s showed decreased l e v e l s compared with age-matched c o n t r o l s ( p < 0.01 ), 11 being below normal range. W e conclude t h a t although t h e dynamic t e s t s i n d i c a t e a normally functioning adrenal c o r t i c o s t e r o i d s e c r e t i o n i n GH-deficient subjects t h e l e v e l of DHA i s of pathophysiologic a l i n t e r e s t and may i n d i c a t e towards a d i f f e r e n t mechanism with regard t o t h e regulation f o r t h i s hormone.
19 WIEZMAN* and Z. LARON. I n s t i t u t e of P e d i a t r i c and Adolescent Endocrinology, Beilinson Medical Center and t h e Dept. of Adolescent Psychiatry D, Geha Psychatric Hosp i t a l , Tel Aviv University, I s r a e l . Non-specific growth hormone stimulation by s y n t h e t i c LH-RH i n adolescent schizophrenics.
The e f f e c t of LH-RH (50 mcg/m2, i.v.) on theplasma growth hormone (hGH), p r o l a c t i n (Prl) and gonadotrophins (Gn) was s t udied i n 10 adolescent schizophrenic boys, aged 15 8/12 + 4/12 years (m+SE). Their height, weight and pubertal s t a g e s were approprizte t o t h e i r chronological age. As c o n t r o l s served 9 matched normal boys. Before i n i t i a t i o n o f antipsychotic t r e a tment i n 8 out of t h e 10 schizophrenics LH-RH induced a marked r i s e of t h e plasma hGH from 2.5 + 0.6 (meSE) t o 15.5 + 2.4 ng/ m l (p < 0.001) a t 45-90 mins. N; effect-was observed-in t h e normal controls. The mean plasma P r l l e v e l s showed a s l i g h t but n o t s i g n i f i c a n t increase from 8.4 + 1.4 t o 12.7 + 1.5 ng/ml.
The Gn response t o LH-RH was appropriate f o r t h e r e s p e c t i v e pubertal s t a g e i n a l l p a t i e n t s . Six p a t i e n t s were restudied 3 mos following treatment with t h e antidopaminergic drugs (chlorpromazine, t h i o r i d a z i n e o r haloperidol). Their basal P r l r o s e t o 27 t o 300 ng/ml. Their mean basal plasma hGH l e v e l was 2.0 2 0.6 ng/ml and only one boy maintained a p o s i t i v e hGH response t o LH-RH. I t i s postulated t h a t t h e abnormal stimulation of hGH by LH-RH i n young schizophrenics i s caused by an excess b r a i n * *
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P e d i a t r i c and Adolescent Endocrinology, Beilinson
Medical Center 8 Sackler School of Medicine, Tel Aviv University, I s r a e l . Oral clonidine, an e f f e c t i v e hGH provocative t e s t .
A s i n g l e o r a l dose of clonidine -HC1 (0.15 mg/m ) administ e r e d t o 26 healthy s u b j e c t s (17 M and 9 F) aged 6 -17 years induced a marked and c o n s i s t e n t increase i n plasma hGH from 4.9 + 1.3 ng/ml (m+SEM) t o 34.6 + 4.5. These values were highFr than those r e g i s t e r e d durrng i n s u l i n (0.1 U/kg i.v.) hypoglycemia i n 5 of t h e s e children (12.2 + 1.7 ng/ml) . No f a l s e negative responses were observed. In 7 proven hGH d e f ic i e n t p a t i e n t s no change of t h e low basal hGH l e v e l s was found. Plasma i n s u l i n and c o r t i s o l l e v e l s decreased i n both healthy and hypopituitary children. by 50% from baseline. No s i g n i f icant change i n blood glucose, hPrl. LH, FSH and TSH was found.
Blood pressure decreased by 20 + 2 mm Hg (@EM) i n t h e healthy subjects and 25 + 4 mm Hg i n t h e hGH d e f i c i e n t p a t i e n t s . Drows i n e s s was t h e only noted s i d e e f f e c t . Clonidine probably enhances hGH and i n h i b i t s i n s u l i n s e c r e t i o n v i a an a adrenerg i c stimulation. I t is concluded t h a t administration o f o r a l clonidine is a simple potent and r e l i a b l e hGH provocative t e s t .
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FRANCOIS. Service de p b d i a t r i e Sbis, h a p i t a l Edouard
Herriot and U.E.R. Alexis C a r r e l , Lyon, France. Evalua t i o n of a s h o r t intravenous metyrapone (SU) t e s t i n children.
The SU t e s t remains t h e b e s t a v a i l a b l e i n t h e assessment of t h e a c t i v i t y of t h e pituitary-adrenal a x i s . However, i n t h e most usual procedures, using o r a l SU, it i s an expensive t e s t due t o t h e 2 t o 5 days h o s p i t a l i z a t i o n .
W e have evaluated a protocole using IV.SU i n 25 normal i n f a n t s and children (age 9m t o 14.5 y ) and 9 p a t i e n t s (9 t o 18 y ) with p i t u i t a r y adrenal dysfunction a tt e s t e d by t h e c l a s s i c a l o r a l SU t e s t . SU (lg/m2) was infused i n 300 ml/m2 of s a l i n e f o r 2hours (NB : t h e infusion was p a i n f u l with smaller s a l i n e d i l u e n t volume). Plasma c o r t i s o l ( F ) , 11 deoxycortisol ( S ) and ACTH were determined by competitive p r o t e i n binding assays and radioimmunoassay a t 0.2.3 and 4h. The main hormonal changes were observed a t 3 and 4h : F (pg/100ml) decreased from mean +_ SD 15.3 ? 5.6 t o 3.1 2 1.8 ; S increased from mostly undetectable values ((0.1 i n 21/25 t o 1.4) t o 6.4-22 pg/ 100ml. The changes i n plasma ACTH were unconsistant. I n t h e 9 pat i e n t s F decreased from 6.9 ? 4.9 t o 1.2 ? 1.0 pg/100ml. Low bas a l S values ((0.1 i n 8/9 and 1 ) increased t o 1.7-6.8 pg/100ml ; only 1 p a t i e n t reached a plasma S value overlapping t h e normal range. There was no remarkable change i n plasma ACTH. There was no p a r t i c u l a r s i d e -e f f e c t . I n conclusion, a 2h IV.SU t e s t using plasma S determinations a t 0 , 3 and 4h appears a s s a f e , r e l i a b l e , and inexpensive f o r t h e assesment of t h e a c t i v i t y of t h e p i t u i t ary-adrenal a x i s . There seems no advantage i n using plasma F or ACTH determinations. --Dynamic t e s t i n g s f o r p i t u i t a r y and adrenal a c t i v i t y i n 2 bloodr e l a t e d children (boy 10.5 y r ; g i r l 8.0 y r ) with juvenile hypertensive syndrome associated with low plasma renin a c t i v i t y and o t h e r c h a r a c t e r i s t i c symptoms of mineralocorticoid excess f a i l e d t o show any overproduction of aldosterone. For other s t e r o i d s a l s o t h e p r o f i l e s were not grossly deviated except androgen and DOC excretions were s l i g h t l y elevated. Both subj e c t s were without any v i r i l i z a t i o n and d a i l y 25 mg of c o r t i s o l f a i l e d t o improve c l i n i c a l condition. Histological study of t h e male s u b j e c t ' s adrenal cortex revealed strangely not hyperp l a s i a but hypoplasia. Daily dexamethasone treatment improved hypertension and hypokalemic a l k a l o s i s . Extensive analysis of urinary s t e r o i d s revealed t h e existence of 5a and 5f3 epimers (not separated) of dihydrocortisol (boy 107.04 ug; g i r l 91.16/ug) and dihydrocortisone (boy 87.881 u g ; k i r l 80.84 ug) where t h e former was present i n much large4 q u a n t i t i e s than t h a t found by Ulick e t a l . (1977) i n a 3-yr-old g i r l and r e c e n t l y postulated a s an e f f e c t i v e mineralocorticoid by Marver and Edelman ( 1978) . dopaminergic-a c t i v i t y . -
